Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases

Schiergens, 2017, Multidisciplinary treatment of colorectal liver metastases, Minerva Med, 10.23736/S0026-4806.17.05371-X Araujo, 2015, Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis, Ann Surg Oncol, 10.1245/s10434-014-4354-6 Makowiec, 2018, Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy, Int J Colorectal Dis, 10.1007/s00384-017-2916-3 Omichi, 2018, Liver resection is justified for patients with bilateral multiple colorectal liver metastases: a propensity-score-matched analysis, Eur J Surg Oncol, 10.1016/j.ejso.2017.11.006 Pawlik, 2006, Debunking dogma: surgery for four or more colorectal liver metastases is justified, J Gastrointest Surg, 10, 240, 10.1016/j.gassur.2005.07.027 Abdalla, 2004, Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases, Ann Surg, 239, 818, 10.1097/01.sla.0000128305.90650.71 Wang, 2017, Long-term postoperative survival prediction in patients with colorectal liver metastasis, Oncotarget, 8, 79927, 10.18632/oncotarget.20322 Choti, 2002, Trends in long-term survival following liver resection for hepatic colorectal metastases, Ann Surg, 235, 759, 10.1097/00000658-200206000-00002 Sahani, 2014, Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma, Ann Surg, 259, 861, 10.1097/SLA.0000000000000525 Benson, 2013, Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines, J Natl Compr Cancer Netw, 11, 141, 10.6004/jnccn.2013.0022 Bajpai, 2009, Recent progress in imaging of colorectal cancer liver metastases, Current Colorectal Cancer Rep, 5, 99, 10.1007/s11888-009-0015-8 Bipat, 2005, Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis, Radiology, 237, 123, 10.1148/radiol.2371042060 Chen, 2012, Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases, PLoS One, 7, e48681, 10.1371/journal.pone.0048681 Floriani, 2010, Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis, Int J Magn Reson Imaging, 31, 19, 10.1002/jmri.22010 Niekel, 2010, Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment, Radiology, 257, 674, 10.1148/radiol.10100729 Wiering, 2005, The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases, Cancer, 104, 2658, 10.1002/cncr.21569 Koh, 2012, Liver-specific contrast agents, Cancer Imaging, 12, 363, 10.1102/1470-7330.2012.9022 Van Beers, 2012, Primovist, eovist: what to expect?, J Hepatol, 57, 421, 10.1016/j.jhep.2012.01.031 Huppertz, 2004, Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings, Radiology, 230, 266, 10.1148/radiol.2301020269 Thompson, 2008, Contrast agent approved for liver imaging, Am J Health Syst Pharm, 65, 1490 Jhaveri, 2015, Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid), Am J Roentgenol, 204, 498, 10.2214/AJR.13.12399 Vreugdenburg, 2016, Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis, Int J Colorectal Dis, 31, 1739, 10.1007/s00384-016-2664-9 Cho, 2015, Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer, World J Surg, 39, 1161, 10.1007/s00268-015-2944-5 Kim, 2014, Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques, Radiology, 274, 712, 10.1148/radiol.14140390 Muhi, 2011, Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI, J Magn Reson Imaging, 34, 326, 10.1002/jmri.22613 Zech, 2014, Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases, Br J Surg, 101, 622 Hammerstingl, 2002, Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient, Acad Radiol, 9, S119, 10.1016/S1076-6332(03)80415-4 Beets-Tan, 2014, Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases, Br J Surg, 101, 613, 10.1002/bjs.9465 Maher, 2017, The management of colorectal liver metastases, Clin Radiol, 72, 617, 10.1016/j.crad.2017.05.016 Smith, 2009, Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases, Br J Surg, 96, 1101, 10.1002/bjs.6735 Sofue, 2014, Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?, Eur Radiol, 24, 2532, 10.1007/s00330-014-3233-7